Keynote Session: The Needs and Challenges of Using Ocular Tissue and Cells in Cell-Based Therapies

Stem cell-derived products have the potential to provide ocular tissue and therapeutic factors to treat a variety of ocular diseases. Steven Becker, PhD,  Associate Director of the National Eye Institute (NEI) Office of Regenerative medicine will highlight NIH-funded regenerative medicine programs and will discuss the implications they may have for vision research and the development of future therapies. A Q&A session will be moderated by Jennifer Li, MD. 

Steven Becker

Associate Director

NEI Office of Regenerative Medicine

Steven Becker, PhD, joined the National Eye Institute (NEI) in 2014.  He currently leads several regenerative medicine programs as the Associate Director of the Office of Regenerative Medicine. Dr. Becker participates on a number of other projects including the NIH Regenerative Medicine Innovation Project (RMIP), the BRAIN Initiative resource dissemination team, and the National Academies of Sciences, Engineering, and Medicine Forum on Regenerative Medicine. Dr. Becker has a BA in biology from the University of Virginia and a PhD in cell biology from Yale University.

Jennifer Li, MD

Medical Director

Sierra Donor Services Eye Bank

Jennifer Li, MD, is a Professor of Ophthalmology at the UC Davis Eye Center where she is the Director of the Cornea and External Disease Service and the Fellowship Director. Dr. Li received her medical degree and completed her residency at the Baylor College of Medicine in Houston, Texas and subsequently completed a fellowship in Cornea, External Disease and Refractive Surgery at UC Davis. She is also the Co-Medical Director of Sierra Donor Services in Sacramento, California. Dr. Li is an active member of the EBAA serving on the EBAA Accreditation Board and the Scientific Programs Committee. She is the current Chair of the EBAA Medical Advisory Board, Chair-Elect for the EBAA, and a member for the EBAA Board of Directors and Governance Committee.  She is the recipient of the EBAA's 2021 R. Townley Paton Award.


Keynote Session: The Needs and Challenges of Using Ocular Tissue and Cells in Cell-Based Therapies
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin.
Session Evaluation
4 Questions
1.00 CEU credit  |  Certificate available
1.00 CEU credit  |  Certificate available